Imlay, Hannah <br/><br/>
Impact of valganciclovir prophylaxis duration on cytomegalovirus disease in high-risk donor seropositive/recipient seronegative heart transplant recipients.  [electronic resource] 

 -  Transplant infectious disease : an official journal of the Transplantation Society  Jun 2020 
 - e13255 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1399-3062 
<br/><br/><label>Standard No.: </label>10.1111/tid.13255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>Cytomegalovirus Infections--prevention & control<br/>Female<br/>Heart Transplantation<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Risk Factors<br/>Tissue Donors<br/>Transplant Recipients<br/>Valganciclovir--therapeutic use